The idea for this review came after reading a very interesting and well-documented case report last year in @AnnalsofIM. A 76-yr-old patient developed myotoxicity after initiating #canagliflozin. But myotoxocity is not a known adverse effect of SGLT2i... h
239 followers
20,883 followers
RT @AlexGtrzD: We must be careful to confirm or not this event, in an increasingly frequent combination (statins & SGLT2) Rosuvastatin Myot…
343 followers
We must be careful to confirm or not this event, in an increasingly frequent combination (statins & SGLT2) Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report | Annals of Internal Medicine https://t.co/07tzaRXOmI @SENefrolog
168 followers
intriguing 🧵